Multiple Myeloma Academy – COMy 2025 – From Thalidomide to CELMoDs: A Clinical Journey – Monday, August 25, 2025
Open to access this content
0.5 Credit
Management of Mantle Cell Lymphoma: an Update
Open to access this content
Management of Mantle Cell Lymphoma: an Update Read More »
New drugs in low-risk MDS: where do we stand?
Open to access this content
New drugs in low-risk MDS: where do we stand? Read More »